Ironwood Pharmaceuticals Inc. (IRWD) Financial Statements (2026 and earlier)

Company Profile

Business Address 100 SUMMER STREET, SUITE 2300
BOSTON, MA 02110
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

3/31/2026
MRQ
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments215,45688,55992,154656,203620,129362,564
Cash and cash equivalent215,45688,55992,154656,203620,129362,564
Restricted cash and investments    1,2501,2501,735
Receivables46,74581,886129,122115,458114,042122,351
Derivative instruments and hedges, assets     1,115 
Other undisclosed current assets11,97711,92312,0127,7158,6899,189
Total current assets:274,178182,368233,288780,626745,225495,839
Noncurrent Assets
Operating lease, right-of-use asset9,34011,02812,58614,02315,35016,576
Property, plant, and equipment, after accumulated depreciation, depletion, and amortization3,4084,4955,5856,2887,5758,929
Long-term investments and receivables    14,58923,99823,401
Accounts and financing receivable, after allowance for credit loss    14,58923,99823,401
Intangible asset, including goodwill, after accumulated amortization2,0402,8603,682   
Intangible asset, excluding goodwill, after accumulated amortization2,0402,8603,682   
Derivative instruments and hedges      13,065
Restricted cash and investments    485485485
Deferred income tax assets103,433144,234212,324283,661333,294 
Other noncurrent assets4,5025,9233,6088471,000943
Total noncurrent assets:122,723168,540237,785319,893381,70263,399
TOTAL ASSETS:396,901350,908471,0731,100,5191,126,927559,238
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities29,25926,38443,78117,18321,53018,237
Interest and dividends payable✕✕✕✕✕3001,600
Taxes payable✕✕✕✕✕200 
Employee-related liabilities✕✕✕✕✕16,65313,413
Accounts payable2,8982,1277,830483935661
Accrued liabilities26,36124,25735,95116,7003,4422,563
Deferred revenue1,1072,0322,600   
Debt199,680 199,560 116,858 
Derivative instruments and hedges, liabilities    191,316 
Restructuring reserve7715608,303 46210,510
Estimated litigation liability5,000     
Other undisclosed current liabilities6,4019,87021,8578,32321,5323,426
Total current liabilities:242,21838,846276,10125,525161,69832,173
Noncurrent Liabilities
Long-term debt and lease obligation385,000583,988498,309396,251355,817450,574
Long-term debt, excluding current maturities385,000583,988498,309396,251337,333430,256
Liabilities, other than long-term debt31,51829,40942,95826,3653,50113,851
Other liabilities21,64817,10528,4159,7663,5011,763
Operating lease, liability9,87012,30414,54316,59918,48420,318
Derivative instruments and hedges, liabilities      12,088
Total noncurrent liabilities:416,518613,397541,267422,616359,318464,425
Total liabilities:658,736652,243817,368448,141521,016496,598
Equity
Equity, attributable to parent(261,835)(301,335)(346,295)652,378605,91162,640
Common stock163160156154162161
Additional paid in capital1,412,7801,395,3171,355,1951,348,6001,543,3571,528,535
Accumulated other comprehensive income (loss)(1,060)923(3,031)   
Accumulated deficit(1,673,718)(1,697,735)(1,698,615)(696,376)(937,608)(1,466,056)
Total equity:(261,835)(301,335)(346,295)652,378605,91162,640
TOTAL LIABILITIES AND EQUITY:396,901350,908471,0731,100,5191,126,927559,238

Income Statement (P&L) ($ in thousands)

3/31/2026
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Revenues296,151351,410442,735410,596413,753389,523
Cost of revenue(20,257)(2,593)(1,096,323)  (3,136)
Cost of product and service sold      (3,136)
Gross profit:275,894348,817(653,588)410,596413,753386,387
Operating expenses(177,392)(255,693)(291,842)(160,259)(181,538)(243,447)
Other undisclosed operating income    44 
Operating income (loss):98,50293,124(945,430)250,337232,259142,940
Nonoperating income (expense)(28,477)(27,926)(2,639)2,085(31,602)(34,079)
Investment income, nonoperating4,0764,46818,9909,683(452)(4,625)
Interest and debt expense(32,746)(33,034)(21,629)(7,598)(31,150)(29,478)
Income (loss) from continuing operations before equity method investments, income taxes:37,27932,164(969,698)244,824169,50779,383
Other undisclosed income from continuing operations before income taxes32,74633,03421,6297,59831,15029,478
Income (loss) from continuing operations before income taxes:70,02565,198(948,069)252,422200,657108,861
Income tax expense (benefit)(46,008)(64,318)(83,490)(77,357)327,791(2,685)
Income (loss) from continuing operations:24,017880(1,031,559)175,065528,448106,176
Income before gain (loss) on sale of properties:✕✕✕✕✕528,448106,176
Net income (loss):24,017880(1,031,559)175,065528,448106,176
Net income attributable to noncontrolling interest   29,320   
Net income (loss) available to common stockholders, basic:24,017880(1,002,239)175,065528,448106,176
Dilutive securities, effect on basic earnings per share      
Other undisclosed net income (loss) available to common stockholders, diluted  1,157,6744,449  
Net income available to common stockholders, diluted:24,017880155,435179,514528,448106,176

Comprehensive Income ($ in thousands)

3/31/2026
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Net income (loss):24,017880(1,031,559)175,065528,448106,176
Other comprehensive income (loss) 3,954(3,031)   
Comprehensive income (loss):24,0174,834(1,034,590)175,065528,448106,176
Comprehensive income, net of tax, attributable to noncontrolling interest   63   
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(1,983) 29,320   
Comprehensive income (loss), net of tax, attributable to parent:22,0344,834(1,005,207)175,065528,448106,176

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: